Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in TaxesChange in TaxesChange in Working CapitalChange in Working CapitalDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Koninklijke Philips (PHG) Change in Receivables (2010 - 2012)

Koninklijke Philips' quarterly Change in Receivables came in at -$247.7 million in Q4 2012, up 49.64% year-on-year from -$165.5 million in Q1 2012, and up 3.85% quarter-over-quarter from -$257.6 million in Q3 2012.

Koninklijke Philips has reported Change in Receivables for 3 years, with the latest figure at -$247.7 million in Q4 2012.

  • For the quarter ending Q4 2012, Change in Receivables rose 49.64% year-over-year to -$247.7 million; the trailing twelve-month figure through Dec 2012 stood at -$1.3 billion (down 16.47% YoY), and the FY2013 full-year result was -$721.4 million, changed N/A from the prior year.
  • Change in Receivables for Q4 2012 stood at -$247.7 million, up from -$257.6 million in the prior quarter.
  • The five-year high for Change in Receivables was -$147.2 million in Q3 2010, with the low at -$491.9 million in Q4 2011.
  • Average Change in Receivables over 3 years is -$265.2 million, with a median of -$252.7 million recorded in 2012.
  • Year-over-year, Change in Receivables sank 174.42% in 2011 and soared 49.64% in 2012.
  • Tracing PHG's Change in Receivables over 3 years: stood at -$179.3 million in 2010, then tumbled by 174.42% to -$491.9 million in 2011, then soared by 49.64% to -$247.7 million in 2012.
  • The last three Change in Receivables figures came in at -$247.7 million (Q4 2012), -$257.6 million (Q3 2012), and -$491.9 million (Q4 2011), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 42.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -444.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -13.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 117.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 117.90 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -124.60 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -141.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 123.50 Mn
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn -14.50 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2012 -247.71 Mn
Dec 31, 2012 -247.71 Mn
Sep 30, 2012 -257.63 Mn
Sep 30, 2012 -257.63 Mn
Dec 31, 2011 -491.91 Mn
Dec 31, 2011 -491.91 Mn
Sep 30, 2011 -267.37 Mn
Sep 30, 2011 -267.37 Mn
Dec 31, 2010 -179.25 Mn
Dec 31, 2010 -179.25 Mn
Sep 30, 2010 -147.21 Mn
Sep 30, 2010 -147.21 Mn